No immediate trading catalyst. Monitor for any shareholder proposals or director nominations ahead of the July deadlines, which could signal activist interest. The addition of a Medtronic executive to the board may strengthen operational ties, but no deal or material change is announced.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $14.88entry
- T+1 · 5mo ago +0.47%α −0.31% · $14.95
- T+5 · 4mo ago +2.76%α +1.37% · $15.29
- T+20 · 4mo ago +13.10%α +13.38% · $16.83
- T+60 · 8w ago +42.47%α +38.09% · $21.20
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MiniMed Group expanded its board from nine to 11 members, appointing David Endicott (CEO of Alcon) and Linnea Burman (SVP at Medtronic) as independent directors. The filing also sets the 2026 annual meeting for October 9, 2026, with advance notice deadlines for shareholder proposals and director nominations. These are routine governance and scheduling updates with no material financial impact.
Key Facts
- Board size increased from 9 to 11 directors.
- David Endicott (CEO of Alcon) appointed as Class I director, effective June 29, 2026.
- Linnea Burman (SVP & President, Neurovascular at Medtronic) appointed as Class II director, effective June 29, 2026.
- 2026 annual meeting set for October 9, 2026, virtually; record date is August 11, 2026.
- Shareholder proposals under Rule 14a-8 due by July 26, 2026; director nominations and other business due by July 17, 2026.
Financial Impact
No financial figures disclosed; director compensation is consistent with existing non-employee director compensation plan.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-078588 |
| Document: 0001104659-26-078588-index-headers.html | 0001104659-26-078588 |
| Document: 0001104659-26-078588-index.html | 0001104659-26-078588 |
| Document: 0001104659-26-078588.txt | 0001104659-26-078588 |
Track record
25 reports on MMED
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
- Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
- Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
- Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
- Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
- Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
- Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers